The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

Breast cancer represents one of the most common tumor histologies. To date, based on the specific histotype, different therapeutic strategies, including immunotherapies, capable of prolonging survival are used. More recently, the astonishing results that were obtained from CAR-T cell therapy in haem...

Full description

Bibliographic Details
Main Authors: Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli, Ugo De Giorgi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
chimeric antigen receptor (CAR)
macrophages
T cells
immunotherapy
breast cancer
Online Access:https://www.mdpi.com/2072-6694/15/5/1597

Internet

https://www.mdpi.com/2072-6694/15/5/1597

Similar Items